|
31 |
How risky is a second allogeneic stem cell transplantation?
Enthalten in Leukemia Bd. 38, 25.6.2024, Nr. 8, date:8.2024: 1799-1807
|
|
|
|
32 |
How we treat mantle cell lymphoma with cellular therapy in 2025: the European and American perspectives
Enthalten in Bone marrow transplantation Bd. 60, 14.4.2025, Nr. 6, date:6.2025: 759-768
|
|
|
|
33 |
Impact of Resistance Exercise and Nutritional Endorsement on physical performance in patients with GvHD (IRENE-G study) – design and rational of a randomized controlled trial
Enthalten in BMC cancer Bd. 22, 22.4.2022, Nr. 1, date:12.2022: 1-15
|
|
|
|
34 |
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma
Enthalten in Nature medicine Bd. 30, 17.1.2024, Nr. 2, date:2.2024: 507-518
|
|
|
|
35 |
Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation
Enthalten in European journal of clinical microbiology & infectious diseases Bd. 43, 26.6.2024, Nr. 9, date:9.2024: 1679-1688
|
|
|
|
36 |
Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation
Enthalten in Intensive care medicine Bd. 48, 16.4.2022, Nr. 6, date:6.2022: 753-755
|
|
|
|
37 |
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
Enthalten in Nature Communications Bd. 13, 20.10.2022, Nr. 1, date:12.2022: 1-18
|
|
|
|
38 |
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
Enthalten in Blood cancer journal Bd. 14, 15.3.2024, Nr. 1, date:12.2024: 1-8
|
|
|
|
39 |
Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial
Enthalten in Bone marrow transplantation Bd. 57, 18.8.2022, Nr. 11, date:11.2022: 1664-1670
|
|
|
|
40 |
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study
Enthalten in Leukemia Bd. 38, 27.8.2024, Nr. 11, date:11.2024: 2419-2428
|
|
Administration
